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Introduction
The increase in drug resistant bacteria continues to pose a significant threat to human health
worldwide, and new antibiotics are required to combat resistant strains (Center for disease Control
and Prevention, 2013). Drug discovery typically begins with identification of an appropriate target
pathway, isolation of “hit” compounds that inhibit (or dysregulate) the pathway, validation, and
optimization of the hit into a lead compound for development. trans-Translation has been an
intriguing target for new antibiotics because the pathway is required for virulence or viability in
most bacterial pathogens that have been examined, but it is not present in metazoans, so specific
inhibitors might have few side effects (Keiler and Alumasa, 2013; Ramadoss et al., 2013; Giudice
et al., 2014). Recent publication of a high-throughput screen capable of identifying inhibitors
of trans-translation with antibiotic activity validated the pathway as a potential drug target and
provided a key tool for isolating lead compounds (Ramadoss et al., 2013). We argue that this
high-throughput assay, coupled to click-chemistry techniques to identify the molecular targets of
active compounds, should enable widespread efforts to develop drugs targeted to trans-translation.
Reasons for Targeting trans-Translation
trans-Translation is a pathway for rescuing ribosomes trapped at the 3’ end of an mRNA (Keiler
et al., 1996). Bacteria do not use the same mRNA quality control mechanisms employed by
eukaryotes to ensure that mRNAs are intact before translation begins (Keiler, 2008). As a result,
translation can initiate on truncated or damaged mRNAs. In addition, mRNA damage can occur
after ribosomes have initiated translation.When the ribosome reaches the 3′ end of such anmRNA,
there is no stop codon to terminate translation. Estimates in E. coli indicate that ∼2–4% of all
translation initiations terminate in stalled complexes (Ito et al., 2011). Accumulation of these stalled
complexes is lethal, and bacteria require at least one mechanism to rescue stalled ribosomes (Feaga
et al., 2014; Keiler and Feaga, 2014). The primary rescue pathway in bacteria is trans-translation, in
which the protein SmpB and the specialized RNA, tmRNA, recognize stalled ribosomes. During
trans-translation, the ribosome resumes translation on an open reading frame within tmRNA,
adding a peptide tag to the C terminus of the nascent polypeptide and releasing the previously
stalled ribosome. The peptide tag is ultimately recognized by multiple proteases, which degrade the
tagged protein (Keiler, 2008). Genes encoding tmRNA and SmpB have been identified in almost all
bacterial genomes (Hudson et al., 2014). Some species also have backup rescue systems, the ArfA
or ArfB proteins (Chadani et al., 2011, 2012) that can release ribosomes when trans-translation
activity is not available.
A number of key attributes make trans-translation an attractive antibiotic target. First,
it is essential for viability or virulence in many pathogenic species, including Neisseria
gonorrhoeae, Mycobacterium tuberculosis, and Staphylococcus aureus (Huang et al., 2000; Zhang
et al., 2012b; Fey et al., 2013). Disruption of trans-translation also results in hyper-sensitivity
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to antibiotics in some species (Abo et al., 2002; Li et al., 2013).
Second, tmRNA and SmpB are universally conserved in bacteria,
but are absent in metazoans, so specific inhibition of trans-
translation should not cause toxicity in the host (Hudson et al.,
2014). Third, the pathway includes several molecules that are
not targeted by existing antibiotics, including tmRNA, SmpB,
and stalled ribosomes, therefore cross-resistance with existing
antibiotics should be minimal.
An HTS Assay to Identify Inhibitors
To validate trans-translation as a target and to begin the drug
discovery process, an assay for trans-translation inhibitors was
developed and used in a high-throughput screen (Ramadoss
et al., 2013). The assay uses an E. coli strain engineered to express
luciferase from a truncated mRNA. When there is no inhibition,
all the luciferase is tagged by trans-translation and degraded, but
when trans-translation is inhibited active luciferase is produced.
The Z’ score under high-throughput conditions is 0.75, and the
assay is appropriate for a wide range of screening platforms.
Screening of a library of small molecules identified specific
inhibitors that have promising antibacterial properties against
both Gram-positive and Gram-negative bacteria and exhibit low
toxicity against human cells (Ramadoss et al., 2013).
This assay is cell-based, which ensures that hit compounds will
be able to function in the context of the bacterial cell. However,
inhibitors could target one of several potential molecules
including both nucleic acids and proteins (Keiler and Alumasa,
2013; Ramadoss et al., 2013; Giudice et al., 2014), and the
molecular target of each inhibitor must be identified to facilitate
optimization.
Molecular Target Identification Strategies
The main genetic approach to molecular target identification
typically involves isolating and sequencing resistant mutants to
identify candidate targets (Lerner et al., 2005; Wacker et al.,
2012; Schenone et al., 2013). This method is generally successful
when resistant mutants can be obtained (Wacker et al., 2012).
However, there are several reasons why target-based resistance
will be rare or nonexistent: (i) mutations in the target that
eliminate inhibitor activity may themselves be lethal; (ii) multiple
mutations may be required for resistance, for example if the
target is encoded in redundant genes; (iii) there may be multiple
targets for the compound. No target-based resistant mutants
have been obtained for any of the trans-translation inhibitors,
although it is not known why resistance is rare in this case
(Ramadoss et al., 2013).
Alternative approaches to identify molecular targets use
chemical biology, computational, or biochemical techniques
(Schenone et al., 2013). Chemical biology techniques typically
employ the use of small molecule probes that mimic the structure
of the inhibitor. Probe-aided pull down assays, which use an
affinity tag (biotin) fused to the inhibitor, fall into this category.
Although this approach has been shown to work independently,
greater success occurs when it is coupled with orthogonal
methods such as photo-affinity labeling (Li et al., 2004; Kotake
et al., 2007; Yamazaki et al., 2010). A significant drawback of
this approach is that structural modifications performed on the
pharmacophore to incorporate the affinity tag and a linker usually
result in altered physicochemical properties of the probe that
may affect target binding (Kashiwayama et al., 2010; Zhang et al.,
2012a). Click chemistry could provide a solution to this problem
through a two step process incorporating the use of a minimally-
modified pharmacophore for target binding, and a secondary
probe for isolation of the target molecule.
Click Chemistry
The concept of click chemistry broadly encompasses groups
of chemical reactions that are fast, versatile, high yielding and
simple to use (Kolb et al., 2001). The copper catalyzed Azide-
Alkyne Huisgen Cycloaddition (AAHC) is among the most
common click chemistry reactions (Spiteri and Moses, 2010).
AAHC requires both azide and alkyne functional groups, which
react almost exclusively with each other under a defined set of
conditions, minimizing unwanted side reactions (Thirumurugan
et al., 2013). Notable advantages of this method include its
specificity, mild reaction conditions, irreversibility and selectivity
(Kolb and Sharpless, 2003). When applied to molecular target
identification, AAHC can be coupled with methods such as
photo-affinity labeling, making the identification process more
efficient (Sumranjit and Chung, 2013). In the example we
consider here, photo-affinity labeling can be used to covalently
attach a probe to the target, and a subsequent AAHC reaction
can link the probe to a fluorescent moiety or affinity tag to enable
isolation (Figure 1). This strategy circumvents addition of bulky
substituents to the probe that may otherwise affect probe-target
binding.
Compatibility of this reaction with physiological conditions
provides myriad avenues for target identification studies, and
this procedure has been successfully employed to identify
molecular targets for anticancer and antibacterial agents. For
example, the click chemistry approach was used to identify
the target for LW6 an inhibitor targeting the regulation of
tumor angiogenesis and metastasis in colon cancer cell lines
(Lee et al., 2013). Similarly, this procedure was successfully
used to identify inhibitors of the biotin protein ligase possessing
antibacterial activity (Tieu et al., 2013). Many other examples
have been described, demonstrating the efficiency of this method
in identifying molecular targets within biological environments
(Colca et al., 2003; Thirumurugan et al., 2013). It is noteworthy
that the click-based method can be used in live cells, in contrast
to pull-down assays that are normally performed in vitro (Colca
et al., 2003; Speers and Cravatt, 2004). This is an important
property that would allow probe-target interaction to occur in
cells, prior to target isolation. For all such techniques, however,
success is largely dependent upon nature of the probe.
Click Probe Design
Probe design is perhaps the most challenging task requiring
careful assessment in the initial steps of target identification. An
efficient click probe must retain key properties of the parent
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FIGURE 1 | Identification of molecular targets by photo-affinity
labeling and click chemistry. (A) Overview of photo-labile click
probe (PLCP) design, photo-affinity labeling and click bioconjugation
using a fluorescent reporter probe. (B) Cell-based strategy for
click-based molecular target identification for trans-translation inhibitors.
The process involves intracellular probe-target binding, intracellular
probe-target covalent cross-linking, cell lysis, click bioconjugation using
either a secondary fluorescent click probe (SFCP) or secondary affinity
click probe (SACP), target isolation, identification by peptide mass
fingerprinting (PMF), and validation all leading to lead optimization.
Abbreviations: AAHC, Azide-alkyne Huisgen Cycloaddition; FL,
fluorescence-exposed gel; Gel lanes, one ladder; two cell lysate; three
target isolated from a click-based affinity pull-down assay; 4 target
isolated from a click-based fluorescence assay.
molecule, including biological activity and cell permeability,
while accommodating the azide and alkyne moieties that
enable target cross-linking and subsequent click coupling.
Placement of these groups can be guided by structure-activity
relationship (SAR) studies aimed at identifying sites within
the basic pharmacophore that allow modification without
eliminating activity or increasing off-target binding interactions.
A generalized design for a photo-labile click probe (PLCP),
harboring a photo-labile terminal azide group and a terminal
alkyne, is shown in Figure 1A. The azide group in this PLCP
can be activated by UV irradiation to cross-link the PLCP to the
target. The alkyne can then be used for click conjugation to a
secondary probe containing a fluorescent or biotinylated group
to facilitate purification.
Molecular Target Identification
To identify the molecular target, the PLCP can be cross-linked
to interacting molecules in vivo, in a cell extract, or in a purified
system. If the probe is cell permeable, it can be added to bacterial
cells to allow target binding (Figure 1B) (Colca et al., 2003). UV
irradiation (typically 254–366 nm) is then used to activate the
azide and cross-link the PCLP to binding partners. The cells are
lysed under denaturing conditions, excess PCLP is removed, and
the secondary probe is attached via click chemistry. Denaturation
ensures that the click reaction can proceed even if the PCLP
binds in a site that is inaccessible under native conditions. If a
fluorescent secondary probe is attached, gel electrophoresis can
be used to isolate fluorescent bands (Figure 1B). Conversely, if
the secondary probe contains biotin or any other affinity tag, the
target can be isolated on an appropriate affinity resin (Pozdnyalov
et al., 2013). In either case, the target molecule is then identified
by mass spectrometry. If the PLCP is not cell permeable, it can be
added to a cell extract or to purified candidate molecules prior to
UV irradiation, but the rest of the identification procedure would
be unchanged. Once the target is identified, target validation and
lead optimization can proceed.
Summary
trans-Translation is an attractive target for new antibiotic
development because the reaction is required for virulence or
viability in many pathogens, and several small molecules that
inhibit the pathway have been identified (Ramadoss et al.,
2013). A cell-based assay for high-throughput screening has been
engineered, enabling screening of diverse libraries for inhibitors
that are active in vivo (Ramadoss et al., 2013). The click-based
molecular target identification strategy described here should
enable rapid advancement through the hit validation process.
With these tools available, trans-translation should be pursued as
a drug target on many fronts.
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